Welcome to our dedicated page for Cardinal Health SEC filings (Ticker: CAH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cardinal Health, Inc. (NYSE: CAH) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Cardinal Health is an Ohio corporation whose common shares trade on the New York Stock Exchange under the symbol CAH, as noted in multiple Form 8-K filings. These documents give investors detailed insight into the company’s financial condition, governance, capital structure, and material events.
Cardinal Health regularly files Form 8-K current reports to announce significant developments. Recent 8-K filings include disclosures about quarterly and annual financial results, updates to fiscal 2026 non-GAAP earnings per share outlook, entry into material definitive agreements such as credit facilities and receivables purchase amendments, public offerings of notes to help fund acquisitions like Solaris Health, and the completion of those offerings. Other 8-Ks document matters such as the 2025 Annual Meeting of Shareholders and voting results on director elections, say-on-pay, and auditor ratification.
The company’s definitive proxy statement on Schedule 14A (DEF 14A) offers extensive information on corporate governance, Board composition, executive compensation, and shareholder voting items. Cardinal Health’s proxy materials describe its strategic priorities, fiscal performance highlights, Board skills and refreshment, and engagement with shareholders.
Through Stock Titan, users can review Cardinal Health’s periodic and current reports and use AI-powered tools to summarize key points from lengthy filings. These tools help explain complex sections, highlight items such as non-GAAP metrics definitions, capital markets transactions, and credit agreements, and make it easier to track themes like Specialty growth, distribution network investments, and capital allocation. The filings page also surfaces relevant exhibits, including indentures, underwriting agreements, and amendments to financing arrangements, giving a structured view of Cardinal Health’s obligations and governance framework.
Cardinal Health insider filings show multiple equity transactions by Michelle D. Greene, the company's Chief Information Officer. On 08/15/2025 Greene received a grant of 3,476 restricted share units (RSUs) that vest in three equal annual installments beginning 08/15/2026. The filing also discloses withholding of 9,968 shares to satisfy taxes related to the vesting of 6,787 RSUs and 16,362 performance share units, using a prior-business-day closing price of $150.22. On 08/19/2025 Greene sold a total of 13,500 common shares in multiple transactions at weighted-average prices of $148.76 and $149.28, reducing beneficial ownership from 38,444 to 14,976 shares.
Mason Stephen M, an officer (CEO, GMPD Segment) of Cardinal Health, Inc. (CAH), reported multiple transactions in the companys common stock on 08/15/2025 and 08/19/2025. On 08/15/2025 he received a grant of 8,957 restricted stock units (RSUs) that vest in three equal annual installments beginning 08/15/2026, increasing his beneficial holdings to 98,471 shares. Also on 08/15/2025, 30,811 shares were withheld to satisfy tax obligations related to vesting, reducing holdings to 67,660 shares. On 08/19/2025 he sold a total of 41,575 shares in multiple transactions at weighted average prices of about $147.87, $148.83, and $149.39, resulting in 26,085 shares beneficially owned after the reported sales. The Form 4 discloses price ranges and notes weighted-average pricing for those sales.
Deborah Weitzman, an officer (CEO, PSS Segment) of Cardinal Health, reported two transactions on 08/15/2025. She was granted 10,694 restricted share units (RSUs) that vest in three equal annual installments beginning 08/15/2026, increasing her beneficial ownership to 98,923 common shares. Separately, 24,128 shares were withheld to satisfy tax obligations related to the vesting of 14,966 RSUs and 39,100 performance share units, executed at a prior-business-day closing price of $150.22, leaving beneficial ownership of 74,795 common shares. The form is signed by an attorney-in-fact on 08/19/2025.
Cardinal Health CEO Jason M. Hollar reported several equity transactions in August 2025. He received 42,778 restricted share units (RSUs) on 08/15/2025 that vest in three equal annual installments beginning 08/15/2026. To satisfy tax withholding on vested awards, 136,407 shares were withheld in connection with the vesting of 61,869 RSUs and 245,420 performance share units, leaving him with 343,606 shares after that withholding. On 08/19/2025 he sold a total of 107,705 shares in multiple transactions at weighted average prices reported between $147.40 and $149.58, leaving him with 235,901 shares beneficially owned following the sales.
Jessica L. Mayer, Chief Legal/Compliance Officer of Cardinal Health, reported multiple equity transactions in Form 4. On 08/15/2025 she was granted 9,358 restricted share units (RSUs) that vest in three equal annual installments beginning 08/15/2026. Also on 08/15/2025 a disposition of 27,927 shares occurred to satisfy tax withholding related to the vesting of 12,969 RSUs and 49,994 performance share units, at an effective price of $150.22 (closing price on prior business day). On 08/19/2025 she sold shares in multiple transactions: 4,345 at a weighted average $148.08, 33,333 at $148.91, and 400 at $149.52. Her reported beneficial ownership decreased from 114,462 shares following the RSU grant to 48,457 shares after the reported sales and withholding.
Cardinal Health (CAH) Chief Financial Officer Aaron E. Alt reported multiple equity transactions on Form 4. On 08/15/2025 he was granted 11,363 restricted share units (RSUs) that vest in three equal annual installments beginning on 08/15/2026. That grant increased his reported beneficial ownership to 113,759 shares. On the same day, 34,866 shares were withheld to satisfy tax obligations related to the vesting of 10,288 RSUs and 67,448 performance share units, reducing ownership to 78,893 shares. On 08/19/2025 he sold 34,455 shares at a weighted average price of $148.61 (range $148.00–$148.99), reducing ownership to 44,438 shares, then sold an additional 13,788 shares at a weighted average price of $149.19 (range $149.00–$149.58), leaving 30,650 shares reported as beneficially owned after the transactions.
Insider transactions by Cardinal Health (CAH) Chief Human Resources Officer Ola M. Snow are reported. On 08/15/2025 Snow was granted 6,417 restricted share units that vest in three equal annual installments beginning 08/15/2026, increasing direct holdings to 61,768 shares. Also on 08/15/2025 the filer reported withholding and disposition of 18,186 shares to satisfy tax obligations related to the vesting of 9,202 RSUs and 31,813 performance share units, leaving 43,582 shares. On 08/19/2025 Snow sold 23,700 shares at a weighted average price around $148.86 and 4,451 shares at a weighted average price around $149.39, reducing direct holdings to 15,431 shares; 144 shares are held indirectly via a 401(k) plan. The Form 4 is signed by an attorney-in-fact on 08/19/2025.
Cardinal Health (CAH) filed a Form 144 notifying the proposed sale of 42,870 common shares through Merrill (8890 Lyra Dr, Columbus, OH) on or about 08/19/2025. The filing reports an aggregate market value of $6,382,024.00 and shows 238,793,647 shares outstanding. The securities to be sold were acquired by the reporting person via performance stock vest (37,197 shares) and restricted stock vest (5,673 shares), with acquisition dates listed as 08/15/2025; a prior payment date of 02/15/2024 is noted for a portion of the holdings. No securities were reported sold by this person in the past three months. The filer certifies they are not aware of undisclosed material adverse information.
Cardinal Health (CAH) filed a Form 144 notifying a proposed sale of 143,606 common shares through Merrill on the NYSE, with an aggregate market value of $21,400,000 and an approximate sale date of 08/19/2025. The shares represent recently vested awards acquired on 08/15/2025 from Cardinal Health: 136,478 shares from performance stock vesting and 7,128 from restricted stock vesting. The filing reports 238,793,647 shares outstanding and indicates no securities sold by the filer in the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Cardinal Health insider filed a Form 144 to sell 25,151 shares of Common stock on or about 08/19/2025 with an aggregate market value of $4,192,926 and the shares are to be sold on the NYSE. The filing shows the securities were acquired through company grants that vested: one grant vested 06/30/2025 (5,322 shares) and two grants keyed to 08/15/2025 (5,285 restricted shares and 17,544 performance shares). The filer certifies no undisclosed material information.
Note: the filing tables list acquisition rows that sum to 28,151 shares while the notice states 25,151 shares to be sold, which is an inconsistency present in the document.